United States vaccine market is set to surpass US$ 21 Billion threshold by 2025

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.
“United States Vaccines Market 2015 – 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States.
Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.
The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development.
The major companies dominating this market for its products, services and continuous product developments are:
 
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK)
Top 21 Vaccines Covered Under This Report Are:
 
Prevnar/Prevnar 13
Gardasil/Gardasil 9
Fluzone
Varivax
Menactra
Proquad
Pneumovax
FluLaval/Fluarix
Havrix/Twinrix/Engerix-B
MMR II
Adacel
Boostrix
Bexsero
Menveo
Trumenba
Shingrix
Pentacel
Recombivax HB
Rotateq
Rotarix
Pediarix/Infanrix
The Latest Industry Data Included in this Report:
United States Vaccines Market Size & Analysis (2015 – 2025)
United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
United States Vaccines Pricing Trends & Analysis
United States Vaccines Regulatory System
Major Deals in United States Vaccines Market
Promising Vaccines in Clinical Development by Major Companies
Key Market Drivers and Inhibitors of the United States Vaccines Market
Major Companies Analysis
The answers to the following key questions can be found in the report:
What is the size of the United States vaccines market during 2015 -2025?
What will be the revenue generated by each vaccine during the forecast period?
Which major vaccine provides highest market share?
How are the overall market and vaccine type growing?
What are the key drivers and inhibitors in the current market?
What will be the impact of drivers and inhibitors in the future?
What are the various vaccines available in the United States?
How is the market predicted to develop in the future?
Who are the key players in this market space?
Table of Content
1. ExecutiveSummary
 
2. United States Vaccines Market Size & Analysis (2015 – 2025) 
 
3. United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
 
4. Key Drivers and Inhibitors of the United States Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Top 21 Vaccines Market Assessment & Opportunity (Value),2015 – 2025
5.1 Prevnar/Prevnar 13
5.2 Gardasil/Gardasil 9
5.3 Fluzone
5.4 Varivax
5.5 Menactra
5.6 Proquad
5.7 Pneumovax 23
5.8 Fluarix/FluLaval
5.9 Havrix/Twinrix/Engerix-B
5.10 M-M-R II
5.11 Adacel
5.12 Boostrix
5.13 Bexsero
5.14 Menveo
5.15 Trumenba
5.16 Shingrix
5.17 Pentacel
5.18 Recombivax HB
5.19 Rotateq
5.20 Rotarix
5.21 Pediarix/Infanrix
5.22 Other Vaccines
6. United States Vaccines Pricing Trends & Analysis
 
7. United States Vaccines Regulatory System
8. Major Deals in United States Vaccines Market
8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement
9. Key Companies Analysis
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Promising Vaccines in Clinical Development
9.1.3 Recent Development
9.2 GlaxoSmithKline (GSK) 
9.2.1 Business Overview
9.2.2 Promising Vaccines in Clinical Development
9.2.3 Recent Development
9.3 Merck
9.3.1 Business Overview
9.3.2 Promising Vaccines in Clinical Development
9.3.3 Recent Development
9.4 Pfizer
9.4.1 Business Overview
9.4.2 Promising Vaccines in Clinical Development
9.4.3 Recent Development

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: